The selective mineralcorticoid receptor (MR) antagonist eplerenon prevents decompensation of liver cirrhosis.
| Image |  |
|---|---|
| Description | scientific article published on 22 April 2018 |
| Author/s |
author: Alexander Zipprich Michael Gekle |
| Publication date | June 7, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |